Pharmaceutical Drug Regulatory Affairs Journal (PDRAJ)

ISSN: 2642-6315

Upcoming Article

Expedited Development and Approval Pathways for Medicines and Biological Products Regulatory Innovation Evidentiary Challenges and Global Perspectives

Abstract

Expedited pathways for development and approval aim to reduce the time needed to develop or review medicines for serious conditions while maintaining a favorable benefit risk profile

Note: This article has been accepted for publication in the next issue.  A peer‑reviewed version will be posted soon.
Submit Manuscript

Track your Article

Community
Authors 36,216 Editors 5,220
Indexed in
Google Scholar EuroPub Scilit ResearchBIB WorldCat Advanced Science Index ICMJE ISI Index Copernicus
Member
CrossRef ROAD ISSN ISSN

Upcoming Articles view all

Keratin in Dermatology: Molecular Structure, Skin Barrier Function, Disorders, and Therapeutic Applications (CDOAJ)Vaccine-Encoded Spike in the Nucleus? (CDOAJ)Particulate adjuvant combinations modulate the humoral response to hrEGF rP64k while preserving antibody functionality (CPRJ)Impact of Eye Muscle Strengthening and Oculomotor Training on Postural Stability in College Students with Digital Eye Strain: A Quasi-Experimental Pre–Post Interventional Study (OAJKSM)The Role of Artificial Intelligence in Analyzing the Psychological Environments of Personnel from the Perspective of Security and Military Institutions: A Field Study in Bethlehem Governorate (OAJDA)Prediction of Critical Drawdown Pressures for the Onset of Sand Production Using Conventional Triaxial Tests: A Case Study of Himmatnagar Sandstone (PPEJ)Infectious Disease Prevention and Early Detection in Uninsured and Underserved Populations The Critical Role of Free and Charitable Clinics in the United States (JIDTM)Why Freedom of Vision Should Not Cost the Freedom of Feeling: Eye Care in a Changing Climate (OAJO)

About Us

Guidelines

Services

Connect With us